Cargando…

Association of a Marker of N-Acetylglucosamine With Progressive Multiple Sclerosis and Neurodegeneration

IMPORTANCE: N-glycan branching modulates cell surface receptor availability, and its deficiency in mice promotes inflammatory demyelination, reduced myelination, and neurodegeneration. N-acetylglucosamine (GlcNAc) is a rate-limiting substrate for N-glycan branching, but, to our knowledge, endogenous...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brandt, Alexander U., Sy, Michael, Bellmann-Strobl, Judith, Newton, Barbara L., Pawling, Judy, Zimmermann, Hanna G., Yu, Zhaoxia, Chien, Claudia, Dörr, Jan, Wuerfel, Jens Th., Dennis, James W., Paul, Friedemann, Demetriou, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111565/ https://www.ncbi.nlm.nih.gov/pubmed/33970182 http://dx.doi.org/10.1001/jamaneurol.2021.1116

Ejemplares similares

N-acetylglucosamine inhibits inflammation and neurodegeneration markers in multiple sclerosis: a mechanistic trial
por: Sy, Michael, et al.
Publicado: (2023)

N-acetylglucosamine drives myelination by triggering oligodendrocyte precursor cell differentiation
por: Sy, Michael, et al.
Publicado: (2020)

Vitamin D and Disease Severity in Multiple Sclerosis—Baseline Data From the Randomized Controlled Trial (EVIDIMS)
por: Bäcker-Koduah, Priscilla, et al.
Publicado: (2020)

Epigallocatechin Gallate in Progressive MS: A Randomized, Placebo-Controlled Trial
por: Rust, Rebekka, et al.
Publicado: (2021)

Association of Retinal and Macular Damage with Brain Atrophy in Multiple Sclerosis
por: Dörr, Jan, et al.
Publicado: (2011)

Retinal Thickness Analysis in Progressive Multiple Sclerosis Patients Treated With Epigallocatechin Gallate: Optical Coherence Tomography Results From the SUPREMES Study
por: Klumbies, Katharina, et al.
Publicado: (2021)

Increasing cell permeability of N-acetylglucosamine via 6-acetylation enhances capacity to suppress T-helper 1 (T(H)1)/T(H)17 responses and autoimmunity
por: Lee, Sung-Uk, et al.
Publicado: (2019)

Low contrast visual acuity testing is associated with cognitive performance in multiple sclerosis: a cross-sectional pilot study
por: Wieder, Laura, et al.
Publicado: (2013)

Effect of vitamin D supplementation on N‐glycan branching and cellular immunophenotypes in MS
por: Bäcker‐Koduah, Priscilla, et al.
Publicado: (2020)

Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis
por: Paul, Friedemann, et al.
Publicado: (2008)

Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation
por: Cooper, Graham, et al.
Publicado: (2021)

High-dose vitamin D supplementation in multiple sclerosis – results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trial
por: Dörr, Jan, et al.
Publicado: (2020)

Metabolic Changes in the Visual Cortex Are Linked to Retinal Nerve Fiber Layer Thinning in Multiple Sclerosis
por: Pfueller, Caspar F., et al.
Publicado: (2011)

Temporal visual resolution and disease severity in MS
por: Ayadi, Noah, et al.
Publicado: (2018)

Standardization of T1w/T2w Ratio Improves Detection of Tissue Damage in Multiple Sclerosis
por: Cooper, Graham, et al.
Publicado: (2019)

Evaluation of the ‘ring sign’ and the ‘core sign’ as a magnetic resonance imaging marker of disease activity and progression in clinically isolated syndrome and early multiple sclerosis
por: Blindenbacher, Nelly, et al.
Publicado: (2020)

Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis: A Randomized, Placebo-Controlled Trial
por: Bellmann-Strobl, Judith, et al.
Publicado: (2021)

Fingolimod after a first unilateral episode of acute optic neuritis (MOVING) – preliminary results from a randomized, rater-blind, active-controlled, phase 2 trial
por: Albert, Christian, et al.
Publicado: (2020)

7 Tesla MRI of Balo's concentric sclerosis versus multiple sclerosis lesions
por: Behrens, Janina R., et al.
Publicado: (2018)

Optical coherence tomography for retinal imaging in multiple sclerosis
por: Zimmermann, Hanna, et al.
Publicado: (2014)

Imaging markers of disability in aquaporin-4 immunoglobulin G seropositive neuromyelitis optica: a graph theory study
por: Chien, Claudia, et al.
Publicado: (2019)

Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders
por: Ayadi, Noah, et al.
Publicado: (2021)

Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis
por: Gieß, René M., et al.
Publicado: (2017)

Analysis of Lymphocytic DNA Damage in Early Multiple Sclerosis by Automated Gamma-H2AX and 53BP1 Foci Detection: A Case Control Study
por: Rasche, Ludwig, et al.
Publicado: (2016)

Disease Modification in Multiple Sclerosis by Flupirtine—Results of a Randomized Placebo Controlled Phase II Trial
por: Dörr, Jan, et al.
Publicado: (2018)

Functional connectivity dynamics reflect disability and multi-domain clinical impairment in patients with relapsing-remitting multiple sclerosis
por: Romanello, Amy, et al.
Publicado: (2022)

Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders
por: Asseyer, Susanna, et al.
Publicado: (2018)

Association Between Fatigue and Motor Exertion in Patients With Multiple Sclerosis—a Prospective Study
por: Drebinger, Daniel, et al.
Publicado: (2020)

Lateral geniculate nucleus volume changes after optic neuritis in neuromyelitis optica: A longitudinal study
por: Papadopoulou, Athina, et al.
Publicado: (2021)

Increased Serum Neurofilament Light and Thin Ganglion Cell–Inner Plexiform Layer Are Additive Risk Factors for Disease Activity in Early Multiple Sclerosis
por: Lin, Ting-Yi, et al.
Publicado: (2021)

MRI Pattern Recognition in Multiple Sclerosis Normal-Appearing Brain Areas
por: Weygandt, Martin, et al.
Publicado: (2011)

Longitudinal analysis of primary and secondary factors related to fatigue in multiple sclerosis
por: Schließeit, Jana, et al.
Publicado: (2020)

Neural Processes of Psychological Stress and Relaxation Predict the Future Evolution of Quality of Life in Multiple Sclerosis
por: Meyer-Arndt, Lil, et al.
Publicado: (2021)

Microstructural visual system changes in AQP4-antibody–seropositive NMOSD
por: Oertel, Frederike C., et al.
Publicado: (2017)

Fingolimod Therapy in Multiple Sclerosis Leads to the Enrichment of a Subpopulation of Aged NK Cells
por: Schwichtenberg, Svenja C., et al.
Publicado: (2021)

Relations of low contrast visual acuity, quality of life and multiple sclerosis functional composite: a cross-sectional analysis
por: Schinzel, Johann, et al.
Publicado: (2014)

Transient enlargement of brain ventricles during relapsing-remitting multiple sclerosis and experimental autoimmune encephalomyelitis
por: Millward, Jason M., et al.
Publicado: (2020)

Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica
por: Pasquier, Baptiste, et al.
Publicado: (2019)

Subjective and objective assessment of physical activity in multiple sclerosis and their relation to health-related quality of life
por: Krüger, Theresa, et al.
Publicado: (2017)

Maximum walking speed in multiple sclerosis assessed with visual perceptive computing
por: Grobelny, Anuschka, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a5ntauhcod5v3mnbljti4o20e8